DCF — COVENANT MEDICAL CENTER
Enterprise Value: $-1.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.1B
Enterprise Value
$-356.3M
PV of Cash Flows
$-770.3M
PV of Terminal Value
$-1.2B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $701.3M | $-70.3M | -10.0% | $-99.9M | $-90.9M |
| Year 2 | $722.3M | $-65.1M | -9.0% | $-95.7M | $-79.1M |
| Year 3 | $744.0M | $-59.7M | -8.0% | $-91.1M | $-68.5M |
| Year 4 | $766.3M | $-57.6M | -8.0% | $-90.1M | $-61.5M |
| Year 5 | $789.3M | $-57.4M | -7.0% | $-90.8M | $-56.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$680.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10518192655077827
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5